| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2017 | Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan | MING-CHU CHANG ; Wu C.-H.; Yang S.-H.; Liang P.-C.; Chen B.-B.; Jan I.-S.; Chang Y.-T.; Jeng Y.-M. | American Journal of Cancer Research | |||
| 2001 | Papillary adenoma of the bile duct. | Chang Y.T.; Wang H.P.; Sun C.T.; MING-CHU CHANG ; Chang Y.C.; Wu M.S.; Lin J.T. | Gastrointestinal endoscopy | |||
| 2016 | PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis | Chen B.-B.; Tien Y.-W.; MING-CHU CHANG ; Cheng M.-F.; Chang Y.-T.; Wu C.-H.; Chen X.-J.; Kuo T.-C.; Yang S.-H.; Shih I.-L.; Lai H.-S.; Shih T.T.-F. | European Journal of Nuclear Medicine and Molecular Imaging | |||
| 2006 | Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer | Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Hsu C.; Lu Y.-S.; MING-CHU CHANG ; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. | Journal of Gastroenterology and Hepatology (Australia) | |||
| 2009 | Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer | Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; MING-CHU CHANG ; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; Cheng A.-L.; Whang-Peng J.; Chen L.-T. | Cancer Chemotherapy and Pharmacology | |||
| 2006 | Pneumatosis cystoides coli | Chang Y.-T.; MING-CHU CHANG ; Wei S.-C.; Wong J.-M. | Gastrointestinal Endoscopy | |||
| 2002 | Quantitative correlation of Helicobacter pylori stool antigen (HpSA) test with 13C-urea breath test (13C-UBT) by the updated Sydney grading system of gastritis | MING-CHU CHANG ; Chang Y.-T.; Sun C.-T.; Wu M.-S.; Wang H.-P.; Lin J.-T. | Hepato-Gastroenterology | |||
| 2010 | Recurrent cytomegalovirus colitis with megacolon in an immunocompetent elderly man | Lin, Yi-Hsuan; Yeh, Chi-Ju; Chen, Ying-Jen; MING-CHU CHANG ; Su, I-Hao; Cheng, Hao-Tsai | Journal of medical virology | 7 | ||
| 2002 | Risk Factors for intestinal metaplasia in adult residents of Matzu: A cross-sectional study | Chang C.-H.; Wu M.-S.; Chang Y.-T.; MING-CHU CHANG ; Shun C.-T.; Liu C.-Y.; Lin J.-T. | Journal of the Formosan Medical Association | |||
| 2014 | Screening and early detection of pancreatic cancer in high risk population | MING-CHU CHANG ; Wong J.-M.; Chang Y.-T. | World Journal of Gastroenterology | |||
| 2008 | Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer | Chang Y.-T.; MING-CHU CHANG ; Wei S.-C.; Tien Y.-W.; Hsu C.; Liang P.-C.; Tsao P.-N.; Jan I.-S.; Wong J.-M. | Pancreas | |||
| 2007 | Spectrum of mutations and variants/haplotypes of CFTR and genotype-phenotype correlation in idiopathic chronic pancreatitis and controls in Chinese by complete analysis | MING-CHU CHANG ; Chang Y.-T.; Wei S.-C.; Tien Y.-W.; Liang P.-C.; Jan I.-S.; Su Y.-N.; Wong J.-M. | Clinical Genetics | |||
| 2007 | T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis | MING-CHU CHANG ; Chang Y.-T.; Tien Y.-W.; Liang P.-C.; Jan I.-S.; Wei S.-C.; Wong J.-M. | Clinical Chemistry | |||
| 2015 | Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma | Yang C.-Y.; Liau J.-Y.; Huang W.-J.; Chang Y.-T.; MING-CHU CHANG ; Lee J.-C.; Tsai J.-H.; Su Y.-N.; Hung C.-C.; Jeng Y.-M. | American Journal of Translational Research | |||
| 2019 | Thrombospondin-2 is a Highly Specific Diagnostic Marker and is Associated with Prognosis in Pancreatic Cancer | Peng H.-Y.; MING-CHU CHANG ; Hu C.-M.; Yang H.-I.; Lee W.-H.; Chang Y.-T. | Annals of Surgical Oncology | |||
| 2002 | Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma | Wu M.-S.; Huang S.-P.; Chang Y.-T.; Shun C.-T.; MING-CHU CHANG ; Lin M.-T.; Wang H.-P.; Lin J.-T. | Journal of Infectious Diseases | |||
| 2011 | An unusual case of obstructive jaundice | Tung C.-C.; MING-CHU CHANG ; Chang Y.-T. | Gastroenterology | |||
| 2020 | Using probe electrospray ionization mass spectrometry and machine learning for detecting pancreatic cancer with high performance | Chung W.Y.; Correa E.; Yoshimura K.; MING-CHU CHANG ; Dennison A.; Takeda S.; Chang Y.-T. | American Journal of Translational Research | |||
| 2020 | Validation of Indications for Surgery of European Evidence-Based Guidelines for Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms | Jan I.-S.; MING-CHU CHANG ; Yang C.-Y.; Tien Y.-W.; Jeng Y.-M.; Wu C.-H.; Chen B.-B.; Chang Y.-T. | Journal of Gastrointestinal Surgery | |||
| 2007 | 慢性胰臟炎的臨床研究與基因分析 | Chang, Ming-Chu |  |
